Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Mortality in craniopharyngiomas: Data from the last two decades


Author(s): Ntali G, Shafi AM, Karavitaki N
Affiliated Institution / ERN: Evangelismos General Hospital ;
Condition / Disease: Craniopharyngioma
Publication: Best Practice & Research Clinical Endocrinology & Metabolism v39.5 p102049 Year: 2025 ORPHAcode / other: ORPHA54595
DOI: 10.1016/j.beem.2025.102049 Keywords: SMR,craniopharyngioma,mortality,standardized mortality ratio,survival
MTG6

Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling


Author(s): Murakami M, Naruse M, Kobayashi H, Parasiliti-Caprino M, Bioletto F, Brüdgam D, Stüfchen I, Reincke M, St-Jean M, Kraljevic I, Kastelan D, Nevalainen PI, Araujo-Castro M, Sukor N, Nijhoff MF, Matrozova J, Ragnarsson O, Shafigullina Z, Matikainen N, Markou A, Piaditis G, Izawa S, Katabami T, Ichijo T, Tanabe A, Tsuiki M, Kakutani M, Wada N, Masuda S, Bacca AV, Beuschlein F, Maiolino G, Falhammar H, Grytaas MA, Løvås K, Almeida MQ, Furnica RM, Puar T, Kmieć P, Masi S, Bourdeau I, Amar L, Dennedy MC, Fallo F, Deinum J, O’Toole S, Yamada T, Quinkler M, Lacroix A, Kocjan T
Affiliated Institution / ERN: AO City of Health and Science - Turin ; Klinikum der Universität München ;
Condition / Disease: Familial hyperaldosteronism type I
Publication: European Journal of Endocrinology v193.1 p85-96 Year: 2025 ORPHAcode / other: ORPHA403
DOI: 10.1093/ejendo/lvaf117 Keywords: adrenal venous sampling,expert consensus,hypertension,primary aldosteronism,severity classification
MTG1

Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration


Author(s): Groeneweg S, van Geest FS, Martín M, Dias M, Frazer J, Medina-Gomez C, Sterenborg RBTM, Wang H, Dolcetta-Capuzzo A, de Rooij LJ, Teumer A, Abaci A, van den Akker ELT, Ambegaonkar GP, Armour CM, Bacos I, Bakhtiani P, Barca D, Bauer AJ, van den Berg SAA, van den Berge A, Bertini E, van Beynum IM, Brunetti-Pierri N, Brunner D, Cappa M, Cappuccio G, Castellotti B, Castiglioni C, Chatterjee K, Chesover A, Christian P, Coenen-van der Spek J, de Coo IFM, Coutant R, Craiu D, Crock P, DeGoede C, Demir K, Dewey C, Dica A, Dimitri P, Dremmen MHG, Dubey R, Enderli A, Fairchild J, Gallichan J, Garibaldi L, George B, Gevers EF, Greenup E, Hackenberg A, Halász Z, Heinrich B, Hurst AC, Huynh T, Isaza AR, Klosowska A, van der Knoop MM, Konrad D, Koolen DA, Krude H, Kulkarni A, Laemmle A, LaFranchi SH, Lawson-Yuen A, Lebl J, Leeuwenburgh S, Linder-Lucht M, López Martí A, Lorea CF, Lourenço CM, Lunsing RJ, Lyons G, Malikova JK, Mancilla EE, McCormick KL, McGowan A, Mericq V, Lora FM, Moran C, Muller KE, Nicol LE, Oliver-Petit I, Paone L, Paul PG, Polak M, Porta F, Poswar FO, Reinauer C, Rozenkova K, Seckold R, Seven Menevse T, Simm P, Simon A, Singh Y, Spada M, Stals MAM, Stegenga MT, Stoupa A, Subramanian GM, Szeifert L, Tonduti D, Turan S, Vanderniet J, van der Walt A, Wémeau J, van Wermeskerken A, Wierzba J, de Wit MY, Wolf NI, Wurm M, Zibordi F, Zung A, Zwaveling-Soonawala N, Rivadeneira F, Meima ME, Marks DS, Nicola JP, Chen C, Medici M, Visser WE
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ; CHU d'Angers ; Clinical Psychiatric Hospital "Alexandru Obregia" ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Thyroid Hormone Signalling Disorders
Publication: Nature Communications v16.1 Year: 2025 ORPHAcode / other: ORPHA183631
DOI: 10.1038/s41467-025-56628-w Keywords:
MTG8

Aortic Tissue Analysis in Turner Syndrome


Author(s): Donadille B, Valent A, Amemiya K, Rive le Gouard N, Iserin L, Achouh P, Lecot-Connan T, Bruneval P, Siffroi J, Christin-Maitre S
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease: Chromosomal DSD
Publication: Journal of the American College of Cardiology v80.13 p1284-1285 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.jacc.2022.07.017 Keywords:
MTG7

Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study


Author(s): Savarirayan R, Irving M, Harmatz P, Delgado B, Wilcox WR, Philips J, Owen N, Bacino CA, Tofts L, Charrow J, Polgreen LE, Hoover-Fong J, Arundel P, Ginebreda I, Saal HM, Basel D, Font RU, Ozono K, Bober MB, Cormier-Daire V, Le Quan Sang K, Baujat G, Alanay Y, Rutsch F, Hoernschemeyer D, Mohnike K, Mochizuki H, Tajima A, Kotani Y, Weaver DD, White KK, Army C, Larrimore K, Gregg K, Jeha G, Milligan C, Fisheleva E, Huntsman-Labed A, Day J
Affiliated Institution / ERN: Universitätsklinikum Magdeburg ; ERN BOND ;
Condition / Disease:
Publication: Genetics in Medicine v24.12 p2444-2452 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.gim.2022.08.015 Keywords: Achondroplasia,Annualized growth velocity,Anthropometrics,Observational,Pediatrics

Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial


Author(s): Battelino T, Bergenstal RM, Rodríguez A, Fernández Landó L, Bray R, Tong Z, Brown K
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease:
Publication: The Lancet Diabetes & Endocrinology v10.6 p407-417 Year: 2022 ORPHAcode / other:
DOI: 10.1016/s2213-8587(22)00077-8 Keywords:

Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease


Author(s): Cavalcante IP, Berthon A, Fragoso MC, Reincke M, Stratakis CA, Ragazzon B, Bertherat J
Affiliated Institution / ERN: APDP – Diabetes Portugal ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Adrenal Cushing syndrome
Publication: Nature Reviews Endocrinology v18.11 p699-711 Year: 2022 ORPHAcode / other:
DOI: 10.1038/s41574-022-00718-y Keywords:
MTG1

Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity


Author(s): Ferrara UP, Tortora C, Rosano C, Assunto A, Rossi A, Pagano S, Falco M, Simeoli C, Ferrigno R, D’Amico A, Di Salvio D, Cangemi G, Pivonello R, Strisciuglio P, Melis D
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease:
Publication: Scientific Reports v12.1 Year: 2022 ORPHAcode / other:
DOI: 10.1038/s41598-022-07855-4 Keywords:

Differences or Disorders of sex development in Boys: impact on fertility


Author(s): Cavadias I, Touraine P, Ahmed SF
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease:
Publication: Annales d'Endocrinologie v83.3 p177-180 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.ando.2022.04.013 Keywords: Androgen insensitivity,Androgens,Cryptorchidia,DSD,Disorders sexual development,Fertility,Hypospadias,PMDS,Testis
MTG7

Measuring hyperphagia in patients with monogenic and syndromic obesity


Author(s): Zorn S, von Schnurbein J, Schirmer M, Brandt S, Wabitsch M
Affiliated Institution / ERN: Ulm University Medical Center ;
Condition / Disease: Rare Genetic Obesity
Publication: Appetite v178 p106161 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.appet.2022.106161 Keywords:
MTG5

Very low birth weight newborn with diabetes mellitus due to pancreas agenesis managed with insulin pump reservoir filled with undiluted insulin: 16-month follow-up


Author(s): Zanfardino A, Piscopo A, Curto S, Schiaffini R, Rollato AS, Testa V, Miraglia del Giudice E, Barbetti F, Iafusco D
Affiliated Institution / ERN: AOU University of Campania "Luigi Vanvitelli", Naples ;
Condition / Disease:
Publication: Diabetes & Metabolic Syndrome: Clinical Research & Reviews v16.7 p102561 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.dsx.2022.102561 Keywords: Diabetes in infancy,Hybrid closed loop systems,Insulin dilution,Insulin pump,Neonatal diabetes mellitus

KDM1A inactivation causes hereditary food-dependent Cushing syndrome


Author(s): Vaczlavik A, Bouys L, Violon F, Giannone G, Jouinot A, Armignacco R, Cavalcante IP, Berthon A, Letouzé E, Vaduva P, Barat M, Bonnet F, Perlemoine K, Ribes C, Sibony M, North M, Espiard S, Emy P, Haissaguerre M, Tauveron I, Guignat L, Groussin L, Dousset B, Reincke M, Fragoso MC, Stratakis CA, Pasmant E, Libé R, Assié G, Ragazzon B, Bertherat J
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease: Adrenal Cushing syndrome
Publication: Genetics in Medicine v24.2 p374-383 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.gim.2021.09.018 Keywords: ARMC5,Adrenocortical tumors,Cushing syndrome,GIPR,KDM1A
MTG1

Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study


Author(s): Oral EA, Garg A, Tami J, Huang EA, O'Dea LS, Schmidt H, Tiulpakov A, Mertens A, Alexander VJ, Watts L, Hurh E, Witztum JL, Geary RS, Tsimikas S
Affiliated Institution / ERN: UZ Leuven ;
Condition / Disease: Genetic Lipodystrophy
Publication: Journal of Clinical Lipidology v16.6 p833-849 Year: 2022 ORPHAcode / other:
DOI: 10.1016/j.jacl.2022.08.008 Keywords: BROADEN,Diabetes mellitus,Familial partial lipodystrophy,Hypertriglyceridemia,Triglyceride,Volanesorsen
MTG3

Ectopic craniopharyngiomas


Author(s): Ntali G, Khan T, Karavitaki N, Tsermoulas G
Affiliated Institution / ERN: Evangelismos General Hospital ;
Condition / Disease:
Publication: Best Practice & Research Clinical Endocrinology & Metabolism v39.5 p102047 Year: 2025 ORPHAcode / other: ORPHA54595
DOI: 10.1016/j.beem.2025.102047 Keywords: adamantinomatous,craniopharyngioma,ectopic,papillary

The clinical spectrum of adrenal ganglioneuromas extends from severe hypertension to an asymptomatic incidentaloma; two cases and mini review of literature


Author(s): Kardalas E, Kyriakopoulos G, Antonopoulou V, Kyriakou A, Georgiadi S, Tzanela M, Ntali G
Affiliated Institution / ERN: Evangelismos General Hospital ;
Condition / Disease:
Publication: Hormones v24.4 p1199-1208 Year: 2025 ORPHAcode / other: ORPHA1501
DOI: 10.1007/s42000-025-00676-w Keywords: Adrenal ganglioneuroma,Composite,Hypertension,Pheochromocytoma,Schwannian cell

Continuity of Care in Klinefelter Syndrome: Age-Adapted Modules for Standardized Clinical Data Collection (I-KS)


Author(s): Grasemann C, Gravholt CH, Breen L, Aksglaede L, Lucas-Herald A, Alimussina M, Boettcher C, Wernsmann J, Bauer JJ, Bryce J, Carlomagno F, Hannema SE, Isidori A, Mazen I, Nordenstroem A, Ahmed SF
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; University Medical Center Mainz ; Katholisches Klinikum Bochum ; Aarhus University Hospital ; AOU Policlinico Umberto I - Rome ; Amsterdam UMC ; Karolinska University Hospital ;
Condition / Disease: Maternal Androgens
Publication: Endocrine Connections doi:10.1530/ec-25-0196 Year: 2025 ORPHAcode / other: NO XY CODE
DOI: 10.1530/EC-25-0196 Keywords: Klinefelter syndrome,age-adapted modules,life span,registry,transition
MTG7

Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages


Author(s): Václav Jr. H, Manuela V, Michal K, Adéla K, Jana J, Mikuláš K, Pavel D, David N, Václav M, Martin M, Roman L, Václav H
Affiliated Institution / ERN: General University Hospital in Prague ;
Condition / Disease: Prolactinoma
Publication: Journal of Clinical & Translational Endocrinology v41 p100418 Year: 2025 ORPHAcode / other: ORPHA2965
DOI: 10.1016/j.jcte.2025.100418 Keywords: Dopamine agonist,Giant prolactinoma,Hypogonadism,PitNET
MTG6

Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes


Author(s): Roumpou A, Palermo A, Tournis S, Hasenmajer V, Pasieka JL, Kaltsas G, Isidori A, Kassi E
Affiliated Institution / ERN: General Hospital of Athens “LAIKO” ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Hyperparathyroidism
Publication: Endocrine Reviews v46.4 p576-620 Year: 2025 ORPHAcode / other: ORPHA181408
DOI: 10.1210/endrev/bnaf010 Keywords: bone,fracture,hyperparathyroidism,hypoparathyroidism,parathyroid disorders,pseudohypoparathyroidism
MTG2 MTG8

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia


Author(s): Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A
Affiliated Institution / ERN: Hôpital Bicêtre ; Aarhus University Hospital ; Karolinska University Hospital ; Charité Universitätsmedizin Berlin ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Hospices Civils de Lyon ; Hospital Universitari Vall d’Hebron ;
Condition / Disease: X-linked hypophosphataemia
Publication: Nature Reviews Nephrology v21.5 p330-354 Year: 2025 ORPHAcode / other: ORPHA89936
DOI: https://doi.org/10.1038/s41581-024-00926-x Keywords:
MTG2

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia


Author(s): Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A
Affiliated Institution / ERN: Aarhus University Hospital ; Hôpital Bicêtre ;
Condition / Disease: X-linked hypophosphataemia
Publication: Nature Reviews Nephrology v21.5 p330-354 Year: 2025 ORPHAcode / other: ORPHA89936
DOI: 10.1038/s41581-024-00926-x Keywords:
MTG2

Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas


Author(s): Esposito E, Marra G, Catalano R, Maioli S, Nozza E, Barbieri AM, Hantel C, Di Dalmazi G, Sigala S, Geginat J, Cassinotti E, Baldari L, Palmieri S, Mangone A, Berruti A, Ferrante E, Mantovani G, Peverelli E
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AOU-Bologna ;
Condition / Disease: Adrenocortical carcinoma
Publication: International Journal of Cancer v156.6 p1256-1271 Year: 2025 ORPHAcode / other: ORPHA1501
DOI: 10.1002/ijc.35239 Keywords: Wee1,adavosertib,adrenocortical carcinomas,cell cycle regulation,filamin A,therapeutic target
MTG1

Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study


Author(s): Detomas M, Altieri B, Nasi-Kordhishti I, Ryba A, Haberbosch L, Chierigo F, Deutschbein T, Fassnacht M, Mortini P, Flitsch J, Honegger J, Losa M
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ; San Raffaele hospital - Milan ; University Hospital Würzburg ;
Condition / Disease: Prolactinoma
Publication: Journal of Endocrinological Investigation v48.6 p1363-1370 Year: 2025 ORPHAcode / other: ORPHA2965
DOI: 10.1007/s40618-025-02559-8 Keywords: ACTH deficiency,Adrenal insufficiency,Hypogonadism,Hypothyroidism,Prolactinoma,TSH deficiency
MTG6

New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities


Author(s): Lucas-Herald AK, Aksglaede L, Caspersen ID, Ahmed SF, Carlomagno F, Isidori AM
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Other
Publication: Endocrine Reviews doi:10.1210/endrev/bnaf005 Year: 2025 ORPHAcode / other: ORPHA325546
DOI: 10.1210/endrev/bnaf005 Keywords: Klinefelter,bone,cardiovascular,fertility,neurodevelopment,testosterone
MTG7

Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies


Author(s): Fleseriu M, Pivonello R, Newell-Price J, Gadelha MR, Biller BMK, Auchus RJ, Feelders RA, Shimatsu A, Witek P, Bex M, Piacentini A, Pedroncelli AM, Lacroix A
Affiliated Institution / ERN: UZ Leuven ; AOU Federico II - Naples ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: Pituitary adenoma
Publication: Pituitary v28.1 Year: 2025 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s11102-024-01471-3 Keywords: Cortisol normalization,Cushing’s disease,Diabetes,Hypertension,Long-term treatment,Osilodrostat
MTG6

IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly


Author(s): Chiloiro S, Giampietro A, Giambò P, Costanza F, Mattogno PP, Lauretti L, Calandrelli R, Gaudino S, Gessi M, Rindi G, Olivi A, De Marinis L, Doglietto F, Bianchi A, Pontecorvi A, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Acromegaly
Publication: Pituitary v28.1 Year: 2025 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-024-01479-9 Keywords: Acromegaly,Growth hormone,High frequency,IGF-I,Lanreotide autogel,Somatostatin,Somatostatin receptor ligands
MTG6

Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study


Author(s): Iughetti L, Antoniazzi F, Giavoli C, Bellone S, Aversa T, Guazzarotti L, Street ME, Miraglia del Giudice E, Persani L, Pozzobon G, Ragusa L, Stagi S, Tornese G, Zecchino C, Mameli C, Zecchi E, Fedeli P, Zabransky M, Lucaccioni L, Zucchini S
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AOU University of Campania "Luigi Vanvitelli", Naples ; AOUI Verona ; University Hospital Florence ; San Raffaele hospital - Milan ; Meyer Children’s Hospital Florence ; IRCCS Auxologico Italian Institute - Milan ; AOU-Bologna ; University Hospital of Padova ;
Condition / Disease: Combined pituitary hormone deficiencies, genetic forms
Publication: Endocrine doi:10.1007/s12020-025-04162-6 Year: 2025 ORPHAcode / other: ORPHA95494
DOI: 10.1007/s12020-025-04162-6 Keywords:
MTG6

Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery


Author(s): Furnica RM, Devuyst F, Mathey C, Constantinescu SM, De Herdt C, Alexopoulou O, Lhommel R, Maiter D
Affiliated Institution / ERN: University Hospital Liège ; University Hospitals Saint-Luc ; Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ;
Condition / Disease: Cushing disease
Publication: The Journal of Clinical Endocrinology & Metabolism doi:10.1210/clinem/dgaf047 Year: 2025 ORPHAcode / other: ORPHA96253
DOI: 10.1210/clinem/dgaf047 Keywords: 11C-Methionine PET/CT,functional imaging,persistent/recurrent Cushing’s disease,therapeutic intervention
MTG6

Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency


Author(s): Claahsen-van der Grinten HL, Adriaansen BPH, Falhammar H
Affiliated Institution / ERN: Karolinska University Hospital ; Amsterdam UMC ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Journal of Clinical Endocrinology & Metabolism v110.Supplement_1 pS25-S36 Year: 2025 ORPHAcode / other: ORPHA418
DOI: 10.1210/clinem/dgae718 Keywords: bone health,cardiometabolic health,congenital adrenal hyperplasia,hypergonadotropic hypogonadism,testicular adrenal rest tumors,transition of care
MTG7

Cardiometabolic Aspects of Congenital Adrenal Hyperplasia


Author(s): Krysiak R, Claahsen-van der Grinten HL, Reisch N, Touraine P, Falhammar H
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Karolinska University Hospital ; Klinikum der Universität München ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Endocrine Reviews v46.1 p80-148 Year: 2025 ORPHAcode / other: ORPHA418
DOI: 10.1210/endrev/bnae026 Keywords: 21-hydroxylase deficiency,androgens,atherosclerosis,blood pressure,cardiovascular disease,glucocorticoids,insulin resistance,risk factors
MTG7

Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency


Author(s): Boogers LS, Brüggenwirth HT, Wolffenbuttel KP, Hersmus R, Bryce J, Ahmed SF, Lucas-Herald AK, Baronio F, Cools M, Ellaithi M, Globa E, Güran T, Hiort O, Holterhus P, MсElreavey K, Niedziela M, Stancampiano MR, Tosun BG, van Bever Y, Oosterhuis JW, Looijenga LHJ, Hannema SE
Affiliated Institution / ERN: Ghent University Hospital ; Amsterdam UMC ; Karol Jonscher Clinical Hospital of Poznań University of Medical Sciences ;
Condition / Disease: Other
Publication: European Journal of Endocrinology v192.1 p34-45 Year: 2025 ORPHAcode / other: ORPHA98085
DOI: 10.1093/ejendo/lvae154 Keywords: 17beta-HSD deficiency,5alpha-reductase deficiency,disorder of sex development,germ cell cancer,hypogonadism,puberty,testis
MTG7
Page 1 of 3212345...102030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance